www.reuters.com Open in urlscan Pro
2600:9000:235a:0:15:5a3e:9d40:93a1  Public Scan

URL: https://www.reuters.com/business/healthcare-pharmaceuticals/who-tracking-new-eg5-coronavirus-variant-spreading-uk-us-ted...
Submission: On November 27 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to main content

Exclusive news, data and analytics for financial market professionalsLearn more
aboutRefinitiv

 * World
   Browse World
    * Africa
    * Americas
    * Asia Pacific
    * China
    * Europe
    * India
    * Israel and Hamas at War
   
    * Japan
    * Middle East
    * Ukraine and Russia at War
    * United Kingdom
    * United States
    * Reuters NEXT

 * US Election
 * Business
   Browse Business
    * Aerospace & Defense
    * Autos & Transportation
    * Davos
    * Energy
    * Environment
    * Finance
    * Healthcare & Pharmaceuticals
   
    * Media & Telecom
    * Retail & Consumer
    * Future of Health
    * Future of Money
    * Take Five
    * World at Work

 * Markets
   Browse Markets
    * Asian Markets
    * Carbon Markets
    * Commodities
    * Currencies
    * Deals
    * Emerging Markets
    * ETFs
    * European Markets
   
    * Funds
    * Global Market Data
    * Rates & Bonds
    * Stocks
    * U.S. Markets
    * Wealth
    * Macro Matters

 * Sustainability
   Browse Sustainability
    * Boards, Policy & Regulation
    * Climate & Energy
    * Land Use & Biodiversity
    * Society & Equity
   
    * Sustainable Finance & Reporting
    * The Switch
    * Reuters Impact
    * COP29

 * Legal
   Browse Legal
    * Government
    * Legal Industry
    * Litigation
    * Transactional
    * US Supreme Court

 * Breakingviews
   Browse Breakingviews
    * Breakingviews Predictions

 * Technology
   Browse Technology
    * Artificial Intelligence
    * Cybersecurity
    * Space
    * Disrupted

 * More
   Investigations
   Sports
    * Athletics
    * Baseball
    * Basketball
    * Cricket
    * Cycling
    * Formula 1
    * Golf
    * NFL
    * NHL
    * Soccer
    * Tennis
   
   Science
   Lifestyle
   Graphics
   Pictures
   Wider Image
   Podcasts
   Fact Check
   Video
   Sponsored Content
    * Reuters Plus
    * Press Releases
   
   Live

My News

Sign InSubscribe

Healthcare & Pharmaceuticals


WHO CLASSIFIES EG.5 AS COVID-19 'VARIANT OF INTEREST'

By Gabrielle Tétrault-Farber and Leroy Leo
August 9, 202311:08 PM GMT+2Updated a year ago
Text
 * Small Text
 * Medium Text
 * Large Text

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

The World Health Organisation (WHO) logo is seen near its headquarters in
Geneva, Switzerland, February 2, 2023. REUTERS/Denis Balibouse/File Photo
Purchase Licensing Rights, opens new tab
 * Summary

 * WHO calls on countries to share COVID data
 * EG.5 variant has increased transmissibility
 * But EG.5 not seen as having more public health risks

Aug 9 (Reuters) - The World Health Organization on Wednesday classified the EG.5
coronavirus strain circulating in the United States and China as a "variant of
interest" but said it did not seem to pose more of a threat to public health
than other variants.
The fast-spreading variant, the most prevalent in the United States with an
estimated more than 17% of cases, has been behind upticks in the virus across
the country and also has been detected in China, South Korea, Japan and Canada,
among other countries.
Advertisement · Scroll to continue

"Collectively, available evidence does not suggest that EG.5 has additional
public health risks relative to the other currently circulating Omicron
descendent lineages," the WHO said in a risk evaluation.
A more comprehensive evaluation of the risk posed by EG.5 was needed, it added.
COVID-19 has killed more than 6.9 million people globally, with more than 768
million confirmed cases since the virus emerged. WHO declared the outbreak a
pandemic in March 2020 and ended the global emergency status for COVID-19 in May
this year.
Advertisement · Scroll to continue

Maria Van Kerkhove, the WHO's technical lead on COVID-19, said EG.5 had an
increased transmissibility but was not more severe than other Omicron variants.
"We don't detect a change in severity of EG.5 compared to other sublineages of
Omicron that have been in circulation since late 2021," she said.
Director General Tedros Adhanom Ghebreyesus deplored that many countries were
not reporting COVID-19 data to WHO.

He said that only 11% had reported hospitalizations and ICU admissions related
to the virus.
In response, WHO issued a set of standing recommendations for COVID, in which it
urged countries to continue reporting COVID data, particularly mortality data,
morbidity data, and to continue to offer vaccination.
Van Kerkhove said that the absence of data from many countries was hindering
efforts to fight the virus.

"About a year ago, we were in a much better situation to either anticipate or
act or be more agile," she said. "And now the delay in our ability to do that is
growing. And our ability to do this is declining."

Keep up with the latest medical breakthroughs and healthcare trends with the
Reuters Health Rounds newsletter. Sign up here.

Reporting by Leroy Leo in Bengaluru and Gabrielle Tétrault-Farber in Geneva;
Editing by Toby Chopra and Angus MacSwan

Our Standards: The Thomson Reuters Trust Principles., opens new tab

 * Suggested Topics:
 * Healthcare & Pharmaceuticals
 * COVID-19
 * Regulatory Oversight
 * Regulatory
 * Government Health Policy

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Purchase Licensing Rights


READ NEXT

 * Healthcare & PharmaceuticalscategoryAmgen's weight-loss drug fails to impress
   in study; shares plunge
 * Healthcare & PharmaceuticalscategoryBiden proposes expanded Medicare,
   Medicaid coverage of obesity drugs
 * ANALYSISNew mpox vaccines for Congo's children held up by old problem
 * Healthcare & PharmaceuticalscategoryRoche records setback in phase III study
   of two lung cancer drugs
 * Healthcare & PharmaceuticalscategoryRecordati investor CVC taps up potential
   buyers of drugs group, rival says
 * Trump chooses US COVID policy critic Bhattacharya to lead NIH




BUSINESS




 * BLACK FRIDAY: ONLINE MARKETING COSTS JUMP IN BIDDING WAR WITH TEMU AND SHEIN
   
   ANALYSIS · November 27, 2024 · 7:11 AM GMT+1 · 6 min ago
   
   Heavy online marketing spending by Temu and Shein is making it more costly
   for other retailers and brands to reach shoppers on Black Friday, marketing
   and industry experts say, with both platforms bidding heavily on search
   keywords used by competitors.

 * ANALYSISEuro's bruising leaves global investors on edge7:06 AM GMT+1 ·
   Updated 11 min ago
 * ANALYSISInvestors cling to crash protection despite sizzling US stock market
   rally7:05 AM GMT+1 · Updated 13 min ago
 * TechnologycategoryExclusive: China's Hesai to halve lidar prices next year,
   sees wide adoption in electric cars7:01 AM GMT+1 · Updated 16 min ago
 * ANALYSISHow Trump's Mexico tariffs could hurt Europe's auto industry6:59 AM
   GMT+1 · Updated 18 min ago




SITE INDEX


LATEST

 * Home
 * Authors
 * Topic Sitemap
 * Archive
 * Article Sitemap


BROWSE

 * World
 * Business
 * Markets
 * Sustainability
 * Legal
 * Breakingviews
 * Technology
 * Investigations
 * Sports
 * Science
 * Lifestyle


MEDIA

 * 
   Videos
 * 
   Pictures
 * 
   Graphics
 * 
   Podcasts


ABOUT REUTERS

 * About Reuters, opens new tab
 * Careers, opens new tab
 * Reuters News Agency, opens new tab
 * Brand Attribution Guidelines, opens new tab
 * Reuters and AI, opens new tab
 * Reuters Leadership, opens new tab
 * Reuters Fact Check
 * Reuters Diversity Report, opens new tab


STAY INFORMED

 * Download the App (iOS), opens new tab
 * Download the App (Android), opens new tab
 * Newsletters


INFORMATION YOU CAN TRUST

Reuters, the news and media division of Thomson Reuters, is the world’s largest
multimedia news provider, reaching billions of people worldwide every day.
Reuters provides business, financial, national and international news to
professionals via desktop terminals, the world's media organizations, industry
events and directly to consumers.


FOLLOW US

 * X
 * Facebook
 * Instagram
 * Youtube
 * Linkedin


THOMSON REUTERS PRODUCTS

 * WESTLAW, OPENS NEW TAB
   
   BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT,
   ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY.

 * ONESOURCE, OPENS NEW TAB
   
   THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING
   TAX AND COMPLIANCE NEEDS.

 * CHECKPOINT, OPENS NEW TAB
   
   THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE
   PROFESSIONALS.


LSEG PRODUCTS

 * WORKSPACE, OPENS NEW TAB
   
   ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED
   WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE.

 * DATA CATALOGUE, OPENS NEW TAB
   
   BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND
   INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS.

 * WORLD-CHECK, OPENS NEW TAB
   
   SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER
   HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS.

 * Advertise With Us, opens new tab
 * Advertising Guidelines
 * Purchase Licensing Rights, opens new tab

 * Cookies, opens new tab
 * Terms of Use
 * Privacy, opens new tab
 * Digital Accessibility, opens new tab
 * Corrections
 * Site Feedback, opens new tab

All quotes delayed a minimum of 15 minutes. See here for a complete list of
exchanges and delays.

© 2024 Reuters. All rights reserved






WE VALUE YOUR PRIVACY

We and our 152 partners will store and access information on your device with
your consent. Browsing data is collected through the use of cookies to process
personal data. You can give or withdraw your consent by clicking on the `Show
Purposes` button. You can manage your choices and exercise your right to object
on the basis of legitimate interest at any time by clicking on the cog icon at
the bottom left corner of every page.Cookie PolicyPrivacy Statement


HOW AND WHY WE PROCESS PERSONAL DATA

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

Allow All Reject All Show Purposes



Feedback